Exploring truth, wellbeing, and financial freedom.

Category: Questioning Science Page 1 of 2

AstraZeneca COVID-19

AstraZeneca COVID-19 Vaccine: What Was in It, How Effective Was It, What Adverse Reactions Were Reported, and Why Was It Withdrawn?

An investigation into the Oxford–AstraZeneca vaccine, ingredients, efficacy claims, safety record, patient experiences, regulatory history and the people whose lives were affected.

Introduction

The Oxford–AstraZeneca COVID-19 vaccine, initially known as AZD1222 and subsequently marketed as Vaxzevria, was developed by the University of Oxford in partnership with pharmaceutical company AstraZeneca.

It was one of the principal vaccines used during the UK’s COVID-19 vaccination programme. Its first recipient was 82-year-old Brian Pinker, who received the injection at Oxford’s Churchill Hospital on 4 January 2021.

The vaccine was initially presented as a significant scientific achievement and an important tool in controlling the pandemic. Subseqently, reports emerged of serious adverse reactions, including unusual blood clots, neurological conditions and deaths.

These reports led to additional safety warnings, restrictions on its use in certain age groups and changes to the official product information.

In March 2024, AstraZeneca requested withdrawal of its European marketing authorisation, with the withdrawal taking effect on 7 May 2024.

This article examines what the vaccine contained, its original efficacy figures, recognised adverse reactions, reports submitted to pharmacovigilance systems, experiences of people reporting injuries, books and circumstances surrounding its withdrawal.

It distinguishes between officially recognised adverse reactions, suspected adverse-event reports, individual patient experiences and cases in which coroners established a causal connection.


1. When was AstraZeneca introduced and when was it withdrawn?

The principal dates are:

In the original AstraZeneca clinical trials, the vaccine was reported to have a 70.4% relative risk reduction (RRR) against symptomatic COVID-19. Yet the absolute risk reduction (ARR) was only 1.2%. In simple terms, 1.73% of people in the unvaccinated control group developed symptomatic COVID-19, compared with 0.52% of those vaccinated. The much-publicised 70.4% figure represented a relative reduction in risk, not a 70.4% reduction in everyone’s actual chance of catching COVID-19.

Why was it withdrawn?

The UK had stopped using AstraZeneca in its national COVID-19 vaccination programme in 2022, following the end of its supply arrangements.

In March 2024, AstraZeneca requested withdrawal of the European marketing authorisation. The formal EU withdrawal took effect on 7 May 2024.

This was not “classified” as a safety-motivated recall but did occur against a background of previously identified safety concerns, restrictions and changes to product information.

Sources:

2. What exactly was in the AstraZeneca vaccine?

The vaccine was a viral-vector vaccine. It used a genetically modified chimpanzee adenovirus to deliver genetic instructions for the SARS-CoV-2 spike protein into human cells.

Active ingredient

Chimpanzee adenovirus (ChAdOx1-S), encoding the SARS-CoV-2 spike glycoprotein.

The adenovirus was genetically modified and replication-deficient. It was engineered to carry genetic instructions for the coronavirus spike protein. The adenovirus acted as a vector, delivering the genetic instructions into human cells.

Manufacturing process

The vaccine was produced using genetically modified human embryonic kidney (HEK293) cells and recombinant DNA technology. The official product information explicitly states:

  • The product contains genetically modified organisms (GMOs).
  • The active ingredient is a recombinant, replication-deficient chimpanzee adenovirus vector.
  • HEK293 cells were used in its production.

The use of HEK293 cells in manufacturing should be distinguished from the presence of intact kidney cells in the finished vaccine.

Other ingredients: excipients

The wording supplied from an earlier recipient leaflet lists seven excipients:

  1. L-histidine.
  2. L-histidine hydrochloride monohydrate.
  3. Magnesium chloride hexahydrate.
  4. Polysorbate 80 (E433).
  5. Sucrose.
  6. Disodium edetate dihydrate (EDTA).
  7. Water for injections.

Later UK recipient information and the November 2023 Summary of Product Characteristics list nine excipients.

The additional two are:

  1. Ethanol.
  2. Sodium chloride.

Sodium chloride (ordinary salt, NaCl) is listed as an excipient in the AstraZeneca vaccine. It is also used in lethal-injection protocols.

How much sodium chloride was in AstraZeneca?

The November 2023 MHRA Summary of Product Characteristics lists sodium chloride as an ingredient but does not disclose its individual weight or concentration.

The later nine-item list is reproduced below.

The November 2023 product information states that each 0.5 ml dose contains approximately 2 mg of ethanol and less than 1 mmol (23 mg) of sodium.

What did the vaccine look like?

The product was described as a suspension for injection, colourless to slightly brown, and clear to slightly opaque.

It was supplied in multidose glass vials, including:

  • Eight-dose vials containing 4 ml.
  • Ten-dose vials containing 5 ml.

The vaccine did not contain a preservative.

Sources:

3. AstraZeneca effectiveness: relative risk reduction versus absolute risk reduction

One of the most important issues is the difference between relative risk reduction (RRR = 70%) and absolute risk reduction (ARR 1.2%).

(ARR) is crucial: the actual absolute risk reduction was approximately 1.2%. This calculation rests on the assumption that COVID-19 is primarily a germ-related threat to be prevented or eradicated. An alternative perspective, associated with Antoine Béchamp’s emphasis on the body’s internal terrain, asks us to consider individual health, environmental exposures, toxic burden and the body’s capacity to maintain balance. Daniel Roytas explores this challenge to conventional contagion theory in Can You Catch a Cold?, questioning whether the evidence for person-to-person transmission is as conclusive as commonly assumed. Taken together, these perspectives raise a wider question: should the assessment of a medical intervention focus solely on its ability to reduce the risk of a named infection, or should it consider its effects on the individual’s overall physiological health?

Why does this distinction matter?

The absolute benefit depends on the underlying risk of infection, the duration of observation, previous immunity, circulating variants and other factors.

Source: Voysey et al., Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2, The Lancet, 2021.

https://doi.org/10.1016/S0140-6736(20)32623-4

4. Officially recognised adverse reactions

The MHRA’s product information evolved as new safety signals emerged. November 2023 Summary of Product Characteristics contains the following adverse reactions.

Frequency classifications are:

  • Very common: 1 in 10 or more.
  • Common: 1 in 100 to fewer than 1 in 10.
  • Uncommon: 1 in 1,000 to fewer than 1 in 100.
  • Rare: 1 in 10,000 to fewer than 1 in 1,000.
  • Very rare: fewer than 1 in 10,000.
  • Not known: cannot be estimated from available data.

Very common

  • Headache.
  • Nausea.
  • Muscle pain (myalgia).
  • Joint pain (arthralgia).
  • Injection-site tenderness.
  • Injection-site pain.
  • Injection-site warmth.
  • Injection-site itching.
  • Injection-site bruising.
  • Fatigue.
  • Malaise.
  • Feverishness.
  • Fever.
  • Chills.

Common

  • Vomiting.
  • Diarrhoea.
  • Abdominal pain.
  • Pain in the arms or legs.
  • Injection-site swelling.
  • Injection-site redness.
  • Injection-site induration (hardening).
  • Influenza-like illness.
  • Asthenia (physical weakness or lack of energy).
  • Dizziness.

Uncommon

  • Enlarged lymph nodes (lymphadenopathy).
  • Decreased appetite.
  • Somnolence (sleepiness).
  • Lethargy.
  • Paraesthesia (pins and needles).
  • Hypoaesthesia (reduced sensation).
  • Tinnitus.
  • Excessive sweating.
  • Itching (pruritus).
  • Skin rash.
  • Urticaria (hives).
  • Muscle spasms.

Rare

  • Facial paralysis or facial palsy.

Very rare

  • Guillain-Barré syndrome.
  • Thrombosis with thrombocytopenia syndrome (TTS).

Frequency not known

  • Anaphylaxis.
  • Hypersensitivity.
  • Thrombocytopenia.
  • Immune thrombocytopenia.
  • Cerebrovascular venous and sinus thrombosis.
  • Capillary leak syndrome.
  • Angioedema.
  • Cutaneous vasculitis.
  • Transverse myelitis.

The product information also records extremely rare reports of acute disseminated encephalomyelitis (ADEM), including cases with fatal outcomes. A causal relationship had not been established.  These are the recognised adverse reactions in the product information, not a complete list of every symptom ever submitted to a spontaneous reporting system.

Source: MHRA, Vaxzevria Summary of Product Characteristics, section 4.8, November 2023.

5. Serious adverse reactions requiring particular attention

Thrombosis with thrombocytopenia syndrome (TTS/VITT)

One of the most significant safety concerns associated with AstraZeneca was the development of blood clots alongside low platelet counts.

This became known as thrombosis with thrombocytopenia syndrome (TTS), with vaccine-induced immune thrombotic thrombocytopenia (VITT).

The condition involved abnormal platelet activation and clotting.

Reported locations included:

  • Cerebral venous sinuses.
  • Other veins in the brain.
  • Abdominal veins.
  • Splanchnic veins.
  • Arteries.
  • Other unusual vascular locations.

Patients could develop severe headaches, neurological impairment, haemorrhage, organ damage and, in some cases, death.

The condition was sufficiently serious to prompt changes to national vaccination recommendations and additional warnings in the product information.

Guillain-Barré syndrome

Guillain-Barré syndrome is an immune-mediated neurological condition affecting peripheral nerves.

Possible symptoms include:

  • Weakness.
  • Tingling.
  • Altered sensation.
  • Difficulty walking.
  • Progressive paralysis.
  • In severe cases, respiratory muscle involvement.

The MHRA recognised reports following Vaxzevria.

Transverse myelitis

Transverse myelitis is inflammation of the spinal cord.

Symptoms can include:

  • Limb weakness.
  • Numbness.
  • Tingling.
  • Burning sensations.
  • Pain.
  • Bladder and bowel dysfunction.
  • Difficulty walking.

Extremely rare reports were included in the product information.

Capillary leak syndrome

Capillary leak syndrome is a rare condition in which fluid escapes from small blood vessels into surrounding tissues.

Potential consequences include:

  • Severe swelling.
  • Low blood pressure.
  • Reduced circulating blood volume.
  • Haemoconcentration.
  • Low albumin levels.
  • Potential organ impairment.

Very rare cases were reported, including fatal outcomes.

Acute disseminated encephalomyelitis (ADEM)

ADEM is an inflammatory condition affecting the brain and spinal cord.

Potential symptoms include:

  • Weakness.
  • Numbness.
  • Tingling.
  • Visual impairment.
  • Changes in consciousness.
  • Seizures.

Extremely rare reports, including fatal cases, were recorded following vaccination. The product information did not establish causality.


6. Adverse-event reporting: Yellow Card, VAERS, React19 and UKCVFamily

It is important to examine the systems collecting reports following COVID-19 vaccination.

A. UK MHRA Yellow Card

The Yellow Card scheme collects suspected adverse reactions to medicines and vaccines.

Reports can be submitted by: Members of the public. Healthcare professionals and Pharmaceutical companies.

The scheme includes reports of common reactions, serious medical events, neurological symptoms, cardiovascular problems, blood disorders, hospitalisations and deaths.

Historical AstraZeneca reporting figures

In a parliamentary answer dated 9 February 2022, the Government provided figures up to 15 December 2021.

These are historical figures, not the final cumulative totals. One Yellow Card report can contain multiple suspected reactions.

Source: UK Parliament – Written answer, 9 February 2022.  Further information: https://yellowcard.mhra.gov.uk/

B. VAERS – United States

The Vaccine Adverse Event Reporting System is operated jointly by the US Centers for Disease Control and Prevention and the Food and Drug Administration. AstraZeneca was not authorised for routine use in the US national COVID-19 vaccination programme but clinical trials were conducted.

Official database: https://vaers.hhs.gov/

C. React19

React19 is an organisation established to support people reporting injuries following COVID-19 vaccination, publishing individual accounts, providing resources for people who have experienced vaccine-related harm.

Reported experiences across its community include:

  • Neuropathy.
  • Tinnitus.
  • Brain fog.
  • Fatigue.
  • Gastrointestinal problems.
  • Cardiac symptoms.
  • Muscle and joint pain.
  • Sensory disturbances.
  • Sleep difficulties.
  • Reduced physical functioning.
  • Autonomic dysfunction.
  • Persistent neurological symptoms.

React19 also supports research and education for healthcare professionals. Its accounts are relevant when examining the longer-term experiences of people who have not received adequate medical recognition or support.

Website: https://react19.org/

D. UKCVFamily

UKCVFamily is a UK organisation established to support people reporting adverse reactions and bereavement following COVID-19 vaccination, providing advocacy, information and community support. Public accounts include reports of:

  • Tremors.
  • Burning skin.
  • Tingling and numbness.
  • Neuropathic pain.
  • Headaches.
  • Severe fatigue.
  • Nausea.
  • Tachycardia.
  • Blood pooling.
  • Dizziness.
  • Cognitive difficulties.
  • Reduced mobility.
  • Exercise intolerance.
  • Long-term disability.

Website: https://www.ukcvfamily.org/

A note about Just the Inserts and the Internet Archive

Just the Inserts is another resource worth consulting when examining historical vaccine information, its purpose is to make product information and package inserts accessible and encourage readers to examine the original documentation.

Website: https://justtheinserts.com/

The Internet Archive’s Wayback Machine can also be used to compare historical versions of product information: https://web.archive.org/

For the UK AstraZeneca ingredient lists, the MHRA’s archived recipient leaflets and product characteristics are the primary documentary sources. It is important to retain the date of each leaflet when comparing ingredients, warnings and adverse reactions.


7. Named individuals and their experiences

Individual experiences have become an important part of the public discussion surrounding AstraZeneca. Some cases involve personal accounts of prolonged illness and disability. Others involve formal inquests in which coroners established a connection between vaccination and death.

Brian Pinker – the first UK AstraZeneca recipient

Brian Pinker, aged 82, was the first person outside clinical trials to receive the Oxford–AstraZeneca vaccine. He was vaccinated at Churchill Hospital in Oxford at 7.30 am on 4 January 2021. He was a retired maintenance manager and was receiving dialysis.

His vaccination attracted extensive international media coverage and was presented as a major milestone in the national vaccination programme.

Did Brian Pinker die? There is no reliable obituary, death announcement or subsequent report establishing that Brian Pinker has died.

Caroline Pover – author and UKCVFamily trustee

Caroline Pover is an author and prominent advocate for people reporting COVID-19 vaccine injuries. She has been involved with UKCVFamily and written extensively about experiences of vaccine-injured people. She experienced a serious adverse reaction following AstraZeneca vaccination in March 2021, describing significant deterioration in health and substantial loss of her previous physical capacity, including:

  • Severe acute symptoms.
  • Prolonged health difficulties.
  • Reduced physical functioning.
  • Financial burden of seeking investigations and treatment.
  • Difficulties of navigating medical services.
  • Emotional and practical consequences of living with a vaccine injury.

Her experience subsequently led her to become involved in advocacy and support for other people reporting adverse reactions. Her work is relevant because it combines a personal account with practical guidance for people attempting to organise their medical information and manage prolonged symptoms.

Caroline’s books include Covid Vaccine Adverse Reaction Survival Guide and Worth a Shot? Her personal website: https://carolinepover.com/

Brianne Dressen – AstraZeneca clinical-trial participant

Brianne Dressen was a participant in an AstraZeneca COVID-19 vaccine clinical trial in the United States. She received one injection on 4 November 2020. Her case is significant because she was a clinical-trial participant rather than someone vaccinated during the general public rollout. Her published account illustrates that symptoms began within hours.

Her reported timeline

Her subsequent reported symptoms included:

  • Severe paraesthesia.
  • Blurred and double vision.
  • Tinnitus.
  • Extreme sensitivity to sound.
  • Sensitivity to light.
  • Sensitivity to touch.
  • Limb weakness.
  • Motor dysfunction.
  • Loss of bladder control.
  • Brain fog.
  • Memory difficulties.
  • Neuropathic pain.
  • Internal vibrations and electrical sensations.
  • Tachycardia.
  • Blood pressure fluctuations.
  • Temperature dysregulation.
  • Gastrointestinal problems.
  • Severe fatigue.

Brianne has described substantial long-term disability and difficulty working and caring for her family. She subsequently received assessment and treatment at the US National Institutes of Health, where she was diagnosed with post-vaccination neuropathy, tinnitus, memory problems and severe POTS.

She became a co-chair of React19 and a prominent advocate for people reporting COVID-19 vaccine injuries.

Her legal case

Brianne brought legal proceedings against AstraZeneca in 2024 concerning alleged breach of contract relating to medical costs arising from her participation in the clinical trial. Her case raises important questions about the responsibilities of pharmaceutical companies towards clinical-trial participants who experience serious adverse events.

Sources:

Charlet Crichton – founder of UKCVFamily

Charlet Crichton founded UKCVFamily after experiencing an adverse reaction following COVID-19 vaccination. She previously operated a sports therapy clinic.

Her published account describes:

  • Tremors.
  • Tingling in her legs.
  • Burning skin, particularly at night.
  • Severe nerve pain.
  • Head pain.
  • Severe fatigue.
  • Nausea.
  • Episodes of tachycardia.
  • Blood pooling.
  • Reduced ability to stand and walk for prolonged periods.

She has described losing her business and being unable to continue her previous work because of her health difficulties.

Her experience led her to establish UKCVFamily, which now provides support and advocacy for people reporting COVID-19 vaccine injuries and bereavement.

Source: Patient Safety Learning – Interview with Charlet Crichton.

Lisa Shaw – BBC Radio Newcastle presenter

Lisa Shaw was 44 when she died on 21 May 2021. She received her first AstraZeneca dose in April 2021. A few days after vaccination, she developed severe headaches, subsequently attended hospital and was diagnosed with a blood clot in the brain.

She developed a brain haemorrhage and required specialist treatment, including surgery to relieve pressure on her brain. Despite treatment, she died.

At the inquest in August 2021, Newcastle Senior Coroner Karen Dilks concluded that Lisa had died due to complications of an AstraZeneca COVID-19 vaccination. The pathology evidence supported vaccine-induced thrombotic thrombocytopenia.

This became one of the most widely reported UK cases involving AstraZeneca and brought considerable attention to VITT.

Source: The Guardian, 26 August 2021 – Lisa Shaw inquest.

Dr Stephen Wright – NHS clinical psychologist

Dr Stephen Wright was 32, a father of two and an NHS clinical psychologist and received the AstraZeneca vaccine on 16 January 2021.

On 25 January he awoke with a headache and subsequently developed numbness in his left arm. He developed a cerebral venous sinus thrombosis, suffered a brainstem infarction and experienced a brain haemorrhage. He died on 26 January 2021.

At the April 2023 inquest, Southwark Senior Coroner Andrew Harris concluded that Stephen had died following a rare reaction to the AstraZeneca vaccine.

Source: BMJ – NHS psychologist died after rare reaction to AstraZeneca vaccine, 21 April 2023.

Jack Last – aged 27

Jack Last was an engineer from Stowmarket, Suffolk and received his first AstraZeneca vaccination on 30 March 2021. Approximately a week later he developed headaches and vomiting. He was admitted to hospital, where scans revealed cerebral venous sinus thrombosis. He died on 20 April 2021.

At the inquest in December 2022, Suffolk Senior Coroner Nigel Parsley concluded that Jack had died from a blood clot in the brain caused directly by his body’s reaction to the AstraZeneca COVID-19 vaccination.

Source: BBC – Jack Last died as a result of AstraZeneca vaccine, coroner concludes, 13 December 2022.

Jack Hurn – aged 26

Jack Hurn was a graduate who died on 11 June 2021 following his first AstraZeneca vaccination on 29 May 2021. He developed a persistent headache on 6 June and was admitted to hospital two days later. Investigations revealed extensive cerebral venous sinus thrombosis. He was diagnosed with vaccine-induced immune thrombocytopenia and thrombosis (VITT).

Despite specialist treatment, mechanical thrombectomy and decompressive surgery, his condition deteriorated. At the inquest in May 2022, Birmingham and Solihull Area Coroner Emma Brown concluded:

“Death was due to a rare but recognised complication of the Astra Zeneca COVID19 vaccination.” The coroner also identified concerns about the information given to Jack when he consented to vaccination, in particular, the risk of complications for his age group had been understated.

The official Prevention of Future Deaths report records the medical cause of death as cerebral venous sinus thrombosis and vaccine-induced immune thrombocytopenia and thrombosis.

Source: Judiciary – Jack Hurn Prevention of Future Deaths report.


8. Summary of named cases

These cases demonstrate a range of reported experiences, from prolonged illness and disability to fatal complications formally investigated by coroners. Also illustrating why it is important to retain individual medical histories, inquest findings and patient accounts rather than relying exclusively on aggregate reporting figures.


9. Books documenting AstraZeneca and vaccine-injury experiences

Three books are particularly relevant to understanding the development of the vaccine and the experiences of people reporting adverse reactions.

Covid Vaccine Adverse Reaction Survival Guide – Caroline Pover

Author: Caroline Pover. This practical guide was written from Caroline’s experience of living with an adverse reaction following COVID vaccination. It is intended to help people organise their health information and navigate the difficulties associated with prolonged symptoms.

Its subject matter includes:

  • Understanding physical and cognitive symptoms.
  • Recording symptoms and changes in health.
  • Organising medical appointments.
  • Keeping medical records.
  • Exploring nutrition and recovery approaches.
  • Managing the emotional consequences of prolonged illness.
  • Finding appropriate support.
  • Practical worksheets, charts and diaries.

The book is particularly relevant to people who feel overwhelmed by the process of seeking explanations and assistance for persistent symptoms.

Worth a Shot? – Caroline Pover

Worth a Shot? Secrets of the Clinical Trial Participant Who Inspired a Global Movement – Brianne Dressen’s Story. Author: Caroline Pover. Foreword: Brianne Dressen. Publisher: Skyhorse Publishing. Publication date: 26 November 2024.

ISBN: 9781510783485.

Important correction to the book attribution: Caroline Pover is the author. Brianne Dressen is the subject and wrote the foreword. It tells the story of Brianne’s participation in an AstraZeneca clinical trial and subsequent health difficulties.

Its subject matter includes:

  • Her decision to volunteer for a COVID-19 vaccine trial.
  • The onset of symptoms following vaccination.
  • Her subsequent medical difficulties.
  • Her attempts to obtain explanations and treatment.
  • Her interactions with the pharmaceutical industry.
  • Questions about clinical-trial obligations.
  • The difficulties faced by people reporting trial-related injuries.
  • The emergence of an international vaccine-injury advocacy movement.
  • Questions surrounding pharmaceutical accountability and patient support.

The publisher describes it as part memoir, part medical mystery and part social commentary.

All proceeds from the sale of the book are designated for React19 and UKCVFamily.

Publisher: Simon & Schuster – Worth a Shot?.

Vaxxers – Sarah Gilbert and Catherine Green

Full title: Vaxxers: The Inside Story of the Oxford AstraZeneca Vaccine and the Race Against the Virus. Authors: Professor Sarah Gilbert and Dr Catherine Green. Publisher: Hodder & Stoughton. Published: 2021.

This book provides an account from two scientists directly involved in developing the Oxford vaccine. Its contents cover:

  • The emergence of SARS-CoV-2.
  • The design of the Oxford vaccine.
  • The ChAdOx1 platform.
  • Laboratory development.
  • Manufacturing and scaling up production.
  • Clinical trials.
  • Regulatory approval.
  • The international rollout.
  • Public debate and vaccine confidence.

Unlike the other two books, this is an account of vaccine development from the perspective of the scientists involved.


10. What does the evidence tell us?

The AstraZeneca experience raises important questions about pharmaceutical safety, clinical-trial transparency, adverse-event monitoring, informed consent and the treatment of people reporting injuries.

Regulatory evidence

The MHRA and EMA product information evolved as new adverse reactions were identified and assessed. Recognised safety information eventually included:

  • Thrombosis with thrombocytopenia syndrome.
  • Guillain-Barré syndrome.
  • Capillary leak syndrome.
  • Transverse myelitis.
  • Immune thrombocytopenia.
  • Other neurological and vascular conditions.

The changing product information provides a documentary record of how the recognised safety profile developed.

Pharmacovigilance evidence

Yellow Card reports provide a mechanism for identifying suspected reactions across the population. It is suggested that lower than 10% of adverse reactions are ever reported. Reports may contain several symptoms; the number of reports cannot be equated with the number of confirmed injuries.

The historical reporting figures nevertheless demonstrate the substantial volume of suspected reactions submitted to the MHRA.

Coroner and clinical evidence

The deaths of Lisa Shaw, Dr Stephen Wright, Jack Last and Jack Hurn are particularly significant because coroners formally examined the circumstances and established a connection between vaccination and fatal complications. They are cases supported by formal inquests and documented findings.

Patient experiences and prolonged illness

Caroline Pover, Brianne Dressen, Charlet Crichton and members of UKCVFamily and React19 have described significant changes to their health, employment, independence and quality of life. Their accounts raise questions about the availability of diagnosis, treatment, rehabilitation and financial support for people who believe they have experienced vaccine-related harm.


Conclusion

The Oxford–AstraZeneca vaccine was introduced into the UK vaccination programme on 4 January 2021 and subsequently became a principal vaccine used during the plandemic.

Its active ingredient was a genetically modified, replication-deficient chimpanzee adenovirus carrying genetic instructions for the SARS-CoV-2 spike glycoprotein.

The original clinical-trial results reported a relative efficacy of 70.4% against symptomatic COVID-19, while the absolute risk reduction in the initial pooled analysis was approximately 1.2%. Following widespread use, additional adverse reactions were identified and incorporated into the official product information. These included thrombosis with thrombocytopenia syndrome, Guillain-Barré syndrome, capillary leak syndrome, transverse myelitis and other neurological and vascular conditions.

The Yellow Card reporting system recorded hundreds of thousands of suspected reactions associated with AstraZeneca. These reports formed part of the pharmacovigilance evidence considered by regulators.

The experiences of people such as Caroline Pover, Brianne Dressen and Charlet Crichton demonstrate the importance of documenting and investigating prolonged health difficulties reported following vaccination.

The deaths of Lisa Shaw, Dr Stephen Wright, Jack Last and Jack Hurn also demonstrate that serious and fatal complications were not merely theoretical possibilities. In these individual cases, coroners established a link between AstraZeneca vaccination and fatal outcomes.

AstraZeneca’s European marketing authorisation was formally withdrawn in May 2024 at the company’s request for commercial reasons.

The withdrawal does not remove the importance of understanding the vaccine’s history, preserving the evidence, examining the changing safety information and ensuring that people reporting serious adverse reactions receive appropriate attention, investigation and support.

The central questions remain those of true informed consent, transparent communication of risks, pharmaceutical accountability and the responsibilities of public institutions towards people who experience serious adverse reactions not to mention ongoing financial conflicts of interests.


References and further reading

Official regulatory documents

  1. MHRA – AstraZeneca Summary of Product Characteristics, November 2023
  2. MHRA – Archived recipient information
  3. European Medicines Agency – Vaxzevria withdrawal
  4. MHRA Yellow Card reporting
  5. VAERS – US adverse-event reporting

Clinical trial and efficacy

  1. The Lancet – Oxford/AstraZeneca clinical trial

Patient experiences and advocacy

  1. React19
  2. Brianne Dressen – React19 personal account
  3. Dressen v AstraZeneca – React19 legal update
  4. UKCVFamily
  5. Caroline Pover – personal website
  6. Patient Safety Learning – Charlet Crichton interview

Coroner findings and reporting

  1. BMJ – Dr Stephen Wright inquest
  2. BBC – Jack Last inquest
  3. Judiciary – Jack Hurn Prevention of Future Deaths report
  4. The Guardian – Lisa Shaw inquest

Books

  1. Caroline Pover – Worth a Shot?
  2. Caroline Pover – Covid Vaccine Adverse Reaction Survival Guide.
  3. Sarah Gilbert and Catherine Green – Vaxxers: The Inside Story of the Oxford AstraZeneca Vaccine and the Race Against the Virus.

Historical document archives

  1. Just the Inserts
  2. Internet Archive – Wayback Machine

COVID-19 Vaccines and Myositis: Context, Concerns, and Current Evidence

Cases of myositis following COVID-19 vaccination have been documented. The clinical spectrum includes mild inflammatory myopathy, dermatomyositis, immune-mediated necrotising myopathy, and overlap syndromes. The relationship remains under study.  Be aware that mainstream will say these are “rare” so as not to “undermine” public confidence, but the facts are that widespread adverse reactions are well known.


Findings from the Literature

  • A 2023 review collected 49 cases of inflammatory myositis after COVID-19 vaccination. Muscle involvement was most frequent (~80 %), followed by skin manifestations (~53 %) and interstitial lung disease (~35 %). Most patients received mRNA vaccines.

  • Case reports have described anti-MDA5 dermatomyositis, overlap syndromes, and myositis combined with myocarditis following mRNA vaccination.

  • Symptoms usually onset days to weeks post-vaccine. Workup often reveals elevated CK, MRI muscle oedema, EMG myopathy patterns, and in some cases, myositis-specific antibodies (e.g. anti-MDA5, anti-PM/Scl). Biopsy, when done, shows inflammation, necrosis, and MHC-I upregulation.

  • Treatment generally involves high-dose corticosteroids, often with IVIG or immunosuppressants (methotrexate, mycophenolate, rituximab). Many patients improve, though anti-MDA5 + ILD cases carry higher risk.


Consent, Payments & Research Limitations

  • Under UK law and GMC guidance, informed consent must be obtained before vaccination, meaning patients should receive disclosure of benefits, risks, and alternatives.

  • Many report that full informed consent was not provided, particularly regarding long-term risks, rare adverse events, or ingredient details.

  • In the UK, GP surgeries are paid £7.54 per COVID-19 vaccine dose (plus £10 for housebound patients) and £9.58 per influenza vaccine, along with reimbursement of vaccine cost.

  • Because these payments underpin vaccine delivery further independent research may be underprioritised or underfunded, given the conflict between findings that might lower uptake and maintaining vaccine programme revenue.


Historical / Regulatory Notes

  • COVID-19 vaccination was initially not recommended for younger age groups until safety data were established.

  • Clinical trials and post-marketing surveillance continued well after roll-out; for example, long-term safety data collection extended into January 2023 and beyond.


Key Takeaways

  • Myositis after COVID-19 vaccination is documented but rare.
  • Onset typically occurs within days to weeks of vaccination.
  • Management with immunosuppressants often yields improvement.
  • Informed consent is mandated but often reportedly remains incomplete in practice.
  • GP payment per vaccine (COVID: £7.54 + housebound supplement; flu: £9.58) introduces systemic incentives.
  • Funding priorities and institutional alignment may suppress or disincentivise independent adverse event research.
  • Further prospective, independent studies are needed to assess incidence, mechanisms, and long-term safety.

Key References & Research Links

  1. Syrmou V, et al. COVID-19 vaccine-associated myositis: comprehensive review and case report. Immunologic Research, 2023. — PMC article: pmc.ncbi.nlm.nih.gov/articles/PMC10018601/

  2. González D, et al. Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review. PMC article: pmc.ncbi.nlm.nih.gov/articles/PMC9166182/

  3. Bolla E, et al. New-onset anti-MDA5 dermatomyositis following COVID-19 vaccination. PMC article: pmc.ncbi.nlm.nih.gov/articles/PMC11082759/

  4. Ding Y, et al. Inflammatory myopathy following coronavirus disease vaccination. PMC article: europepmc.org/article/pmc/pmc9634642

  5. Klein CR, et al. Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis after SARS-CoV-2 mRNA vaccination. Rheumatology International (open access) — link.springer.com/article/10.1007/s00296-024-05683-5

  6. Camargo-Coronel A, et al. Idiopathic inflammatory myopathies linked to vaccination against SARS-CoV-2: a systematic review. Reumatismo PDF: reumatismo.org/index.php/reuma/article/download/1548/970/7027

  7. Reumatismo editorial / commentary: Myositis after SARS-CoV-2 vaccination occurs more frequently than assumed. (Reumatismo, 2023) — reumatismo.org

Just the Inserts – summary

Just the Inserts (www.justtheinserts.com)

Just the Inserts is an independent educational platform designed to help individuals better understand the contents of medical product information sheets—known as inserts—for vaccines, pharmaceuticals, and medical devices. The site’s stated mission is to promote transparency, informed consent, and patient autonomy by providing direct access to the same data supplied by manufacturers and government agencies, presented in plain language for everyday readers.

The platform was founded by a parent who experienced a negative reaction in their child following a pharmaceutical product and subsequently discovered how inaccessible and complex official documentation could be. Motivated by this, the founder created a space where users could easily find, read, and interpret the original inserts for themselves rather than relying solely on medical summaries or promotional materials.

Key Features

  1. Insert Search & Archive
    The website provides a searchable library of drug and vaccine inserts. Users can look up ingredients, side effects, contraindications, and manufacturer warnings exactly as they appear on the official documentation.

  2. Educational Course
    A free self-paced course, How to Read an Insert, teaches visitors how to interpret the technical sections of medical product inserts. It walks users through how to recognise warnings, dosage information, and clinical data references.

  3. Vaccine Information Section
    The vaccine section compiles inserts for commonly used vaccines and introduces a concept called the Vaccine Perspective Spectrum™, which aims to broaden the discussion beyond “pro-” or “anti-” vaccination labels. The intention is to encourage nuanced, evidence-based conversation about risks and benefits.

  4. Publications and Resources
    The platform offers supplementary materials such as Well Considered: A Handbook for Making Informed Medical Decisions and an accompanying podcast and newsletter. It also includes a provider directory featuring practitioners who value informed consent.

  5. Ethical and Educational Approach
    Just the Inserts emphasises the principles of transparency, accessibility, and personal responsibility. The site maintains that it does not offer medical advice but provides educational resources for individuals to understand pharmaceutical information independently. Its team states openly that they hold biases toward greater transparency and medical freedom, preferring to make those biases explicit rather than hidden.

  6. Community and Advocacy
    The wider aim of the project is to create a community of people who are better informed, confident in interpreting medical data, and empowered to discuss health decisions with professionals on equal terms. It positions informed consent as the cornerstone of ethical medicine and public trust.

Overview

Just the Inserts bridges the gap between dense scientific language and the everyday individual’s need for clear information. It promotes the view that genuine consent can only exist when people understand exactly what they are consenting to, using official documents rather than media interpretations or government summaries.

While critics may question whether the tone of the platform leans toward medical scepticism, supporters argue that it simply restores balance in a system where patient understanding is often secondary to compliance. The platform does not claim to replace professional advice but to enable citizens to ask better questions of their healthcare providers.


Key Summary Takeaways

  • Purpose: To make medical product inserts accessible and understandable to the public.
  • Mission: Promote transparency, informed consent, and patient autonomy.
  • Core Offerings: Searchable insert database, free educational course, publications, and provider directory.
  • Ethical Stance: Encourages individual responsibility in health choices; critical of one-sided or politically driven narratives.
  • Audience: Individuals seeking to understand vaccine and pharmaceutical risks directly from official sources.
  • Tone: Educational, sceptical of corporate and governmental gatekeeping, and rooted in advocacy for medical freedom.

Suppression of Truths

“Vaccines: How the Truth Is Suppressed” by Dr Vernon Coleman – a summary

Dr Vernon Coleman argues that open debate and honest discussion about vaccination and pharmaceutical safety are systematically suppressed by the medical establishment, government agencies, and media under the influence of the pharmaceutical industry. He recounts personal experiences that, in his view, demonstrate censorship, bias, and conflicts of interest within the healthcare system.


1. Exclusion from Medical Discourse

Coleman begins with an incident involving PasTest, a UK medical education company. Initially invited to speak at a conference about drug safety and adverse reactions, he was later removed from the programme without explanation. The organisers claimed “certain parties” found him “too controversial.” Coleman suspects the pharmaceutical industry or affiliated regulators were responsible. He argues that this exclusion exemplifies how industry pressure shapes which viewpoints are allowed within NHS and professional education contexts.

The conference still proceeded, featuring speakers from the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Association of the British Pharmaceutical Industry, reinforcing Coleman’s view that only establishment-friendly perspectives were represented.


2. Institutional and Media Suppression

Coleman asserts that both government and mainstream media act to silence dissenting medical voices. He notes that despite public interest, newspapers ignored the story of his conference exclusion, describing attempts to contribute evidence about vaccine risks to the London Assembly’s vaccination review, only to find these submissions were omitted from the final report. This appears to be deliberate censorship intended to protect political vaccination targets rather than examine potential risks.

Mainstream journalists largely rely on official sources and pharmaceutical funding, unwilling to challenge corporate interests. Radio and TV programmes do not inviting medical dissenting views to discuss vaccines since these views conflict with official narratives.


3. Vaccination as Political, Not Scientific

Vaccination has become a political rather than scientific matter. Government incentives to increase immunisation rates, such as GP bonuses, are seen as proof that financial motives drive vaccine promotion. Evidence critical of vaccines is systematically excluded from policy-making, leading to one-sided conclusions.

There was a rare radio debate in which a GP initially denied, then reluctantly admitted, that doctors receive payments for administering vaccines— this is potentially emblematic of medical denial and misinformation.


4. Global Control and Commercial Influence

The critique extends beyond the UK, recounting how publication of any vaccine-critical writings can lead to books being banned in China after government intervention. |This illustrates global suppression of dissenting medical opinion.

The pharmaceutical industry, motivated by profit, controls the flow of scientific information. Governments and regulators, fearing financial and reputational fallout, allegedly avoid conducting research that might reveal vaccine harms. The situation is not dissimilar to other industries (e.g., genetically modified foods), where critics are forced to prove danger rather than companies proving safety.


5. Call for Transparency and Scientific Integrity

It is not the job of critics to prove vaccines unsafe, but the duty of manufacturers and public health authorities to prove safety and efficacy. He argues that such evidence is lacking, yet vaccination programmes continue unchecked. Fear of professional reprisal keeps many doctors silent, although it might be argued that there is private support from medical peers who share his concerns.


6. Philosophical and Moral Framing

Suppression of vaccine criticism reflects corruption within medicine, politics, and journalism. Quoting Jerry Weintraub—“If people are scheming to destroy you, it probably means you’re doing something right”— Many critics are actually truth-tellers punished for exposing deception.


Key Summary Takeaways

  • Industry Influence: The pharmaceutical industry dictates what medical professionals and the public are allowed to hear about vaccine safety.

  • Censorship: Critical voices are banned from conferences, media, and public forums.

  • Financial Motives: Doctors and governments promote vaccines due to financial incentives, not science.

  • Media Complicity: Journalists are portrayed as compliant or corrupted, unwilling to publish dissenting evidence.

  • Scientific Reversal: Critics are wrongly tasked with proving vaccines unsafe; instead, promoters should prove safety.

  • Suppressed Evidence: Policymakers allegedly ignore data questioning vaccination safety or necessity.

  • Moral Appeal: The suppression of dissent is a moral and scientific failure endangering public trust and health.


Editorial note: It could be argued that the modern NHS has evolved into a business-oriented system, increasingly driven by profit, political targets, and institutional metrics rather than individual health outcomes. The frequent text reminders urging citizens to “book” or “claim” their vaccine eligibility resemble marketing strategies more than genuine healthcare communication, creating an impression of sales-driven urgency rather than patient-centred care.

The integration of vaccination programmes directly into schools—sometimes without full parental knowledge or informed consent—reinforces the perception of a system prioritising uptake statistics over ethical transparency. While mainstream political narratives tend to frame these policies as measures of “public responsibility,” “efficiency,” or “equity of access,” critics suggest they reveal a deeper alignment between healthcare policy and pharmaceutical interests. The result is an NHS model where meeting government-set performance indicators can appear to outweigh open dialogue, individual risk assessment, and medical autonomy.

The Covid Physician – at Odds with the System

Summary of “The Covid Physician” (31 January 2024)


Introduction: A Physician at Odds with the System

The author, a UK physician writing under “The Covid Physician,” reflects on the aftermath of the COVID-19 era. Remaining unvaccinated and unmasked, he claims the true danger lay not in the virus, but in government policy, coercion, and public compliance. His essay is both a personal testimony and political critique—an account of professional and societal trauma inflicted through what he calls “Reality-Enforcement through Policy.”


Reality-Enforcement and Collective Trauma

The author argues that lockdowns, propaganda, and fear campaigns induced mass psychological trauma—hypervigilance, anxiety, depression, and grief—now normalised as part of daily life. He asserts COVID-19 was “more bureaucratic policy than disease,” with global coordination reflecting an orchestrated, profit-driven agenda rather than a medical emergency. Words like “stay safe” and “build back better” were tools of manipulation, reshaping human behaviour and dividing society through “ancient Statecraft’s divide-and-rule.”


Erosion of Medical Ethics and Professional Freedom

The essay laments the corruption of medicine by the State and pharmaceutical interests. Regulators, he claims, now prioritise enforcing the official narrative over protecting ethical medical practice. Physicians who questioned policy were censored, mocked, and professionally destroyed. “A licence to heal,” he writes, “became a licence to peddle State delusions.”

He describes the medical profession as complicit in abandoning the Hippocratic Oath, calling it “Hippocrates murdered by pharmaceutical fascists.” Many doctors, he suggests, became either compliant or broken, while others—like himself—waged a solitary moral battle within an oppressive system.


Individual and Professional Survival

Haunted by “survivor’s guilt,” the author recounts colleagues who lost livelihoods for dissent. His own survival strategy was to distance himself from the NHS, retrain, and continue practising medicine guided by conscience. He urges others to “reboot from within,” resisting quietly and restoring moral medicine one patient at a time. His goal: to “infiltrate and explode the WHO from within”—a metaphor for dismantling what he views as the epicentre of medical corruption.


Global and Community-Level Manipulation

He provides examples of local government initiatives—such as “Get the vaccine or meet us!” campaigns and financial incentives for community surveillance—as proof of psychological coercion. Charities and media, he claims, were weaponised to enforce obedience and shame dissent. Meanwhile, real public health issues and vaccine harms were ignored.

He portrays the entire pandemic response as a coordinated effort by global elites to traumatise populations into submission, advancing surveillance, digital currencies, and social control.


State and Global Corruption

The UK Covid Inquiry is described as a “State ritual of lie compaction,” destined to absolve perpetrators and reinforce authoritarian control. He views Western democracy as hollow—politics, medicine, and law now serving corporate power. Global crises, from Ukraine to Palestine, are framed as distractions perpetuating “killing-for-profit.”


Path to Recovery: Reclaiming Humanity

Despite despair, the author envisions renewal through individual transformation. True healing, he says, begins with moral courage, integrity, and community rebuilding outside State structures. The goal is a “counter-revolution of conscience” where small acts of truth and compassion erode the machinery of fear.


Key Takeaways

  • Covid as Policy, Not Disease: The author views the pandemic primarily as a political and psychological operation.

  • Mass Trauma: Policies caused long-term collective PTSD, particularly among children.

  • Suppression of Dissent: Medical professionals challenging policy were silenced or exiled.

  • Moral Collapse of Medicine: The Hippocratic tradition replaced by State obedience.

  • Quiet Resistance: Change must begin individually—through ethical action and patient-centred care.

  • Hope through Renewal: The essay closes with a call for personal and societal reawakening beyond propaganda and fear.


“The Covid Physician” ends by framing his writings as artistic and political expression, no longer under the authority of medical institutions—an act of both defiance and liberation.

The Poisoned Needle: Suppressed Facts About Vaccination

A Book Review – The Poisoned Needle – By Eleanor McBean, PhD, ND (1957)


Overview

Originally written and published in 1957, The Poisoned Needle by Eleanor McBean is one of the earliest comprehensive critiques of vaccination policy and medical orthodoxy. The author, a naturopath and health researcher, draws upon medical records, government data, and historical sources to argue that vaccines have not only failed to prevent disease but have caused widespread harm to human health.

McBean positions the book as both an exposé and a warning — revealing what she viewed as deliberate suppression of truth by vested medical and political interests. Her message is that vaccination represents a grave error in scientific understanding and a violation of natural health principles.


1. The False Foundation of Vaccination

McBean begins by dismantling the foundational premise that immunity can be achieved through injecting diseased material. She maintains that health and resistance arise from within the body and cannot be produced through contamination of the blood with toxins or animal matter.

According to McBean, Edward Jenner’s early vaccination experiments lacked genuine scientific method and were rooted in assumption and superstition. She argues that governments and medical authorities adopted vaccination without evidence of its safety or efficacy, turning it into a state-sanctioned medical dogma rather than a scientific practice.


2. Historical Evidence and Disease Decline

Using historical records, McBean shows that the major declines in infectious diseases occurred before vaccination campaigns began. She attributes these improvements to sanitation, hygiene, nutrition, and living conditions — not to vaccines.

Charts and data within the book demonstrate how diseases such as smallpox, cholera, and typhoid fell naturally as standards of living rose. In several documented cases, she notes that compulsory vaccination was followed by an increase in deaths and outbreaks, contradicting the claims of health officials.


3. Medical and Government Suppression

McBean accuses the medical establishment and government agencies of concealing the dangers of vaccination and silencing dissent. Doctors and scientists who reported vaccine injuries were often ridiculed, censored, or stripped of their professional standing.

She explains that medical journals, public health boards, and funding systems have been constructed to promote vaccination while suppressing unfavourable evidence. The result, she says, is a long-standing conspiracy of silence sustained by financial and political power.


4. The Poisoned Body: How Vaccines Harm Health

At the heart of McBean’s thesis is the idea that vaccines pollute the bloodstream with toxic substances such as mercury, formaldehyde, phenol, aluminium, and diseased animal proteins. She argues that this artificial contamination weakens the body’s vitality, disturbs its natural balance, and lays the groundwork for chronic illness.

The author connects vaccination to a range of degenerative conditions, including paralysis, arthritis, neurological disease, heart disorders, and autoimmune dysfunction. She also documents historical reports of “vaccinal syphilis” and “post-vaccinal encephalitis” as examples of the damage caused by early inoculations.


5. Deaths and Documented Cases

McBean presents numerous examples of individuals and populations suffering after vaccination. These include infant fatalities, mass illnesses among soldiers, and epidemics in highly vaccinated regions.

She cites mortality figures showing that death rates rose in parallel with compulsory vaccination laws, while unvaccinated groups often remained healthier. Her conclusion is that vaccination not only fails to prevent disease but contributes directly to its spread and to premature death.


6. The Smallpox and Polio Narratives

Smallpox: McBean challenges the entire history of smallpox vaccination, arguing that the disease declined due to improved hygiene rather than vaccination. She documents cases where heavily vaccinated communities experienced severe epidemics, while unvaccinated regions did not.

Polio: She claims that the mid-20th-century polio epidemic was largely a result of environmental poisoning, particularly through chemical exposure such as DDT, and not a contagious viral infection. McBean maintains that the polio vaccine further intensified health problems under the guise of prevention.


7. Cancer, Syphilis, and Other Disorders

McBean explores the connection between vaccination and degenerative diseases. She references early medical observations showing tumour development and other pathological changes following inoculation.

She also argues that contaminated vaccines introduced syphilis and other infections into healthy individuals, with health authorities choosing to conceal the evidence to avoid public backlash.


8. The Politics of Fear and Profit

Vaccination, according to McBean, is maintained by fear rather than science. Public health campaigns exploit emotional manipulation, warning of deadly epidemics to ensure compliance. Behind these campaigns, she says, lies a vast commercial interest — pharmaceutical companies, government contracts, and professional prestige.

She calls vaccination a “sacred cow” of modern medicine, protected by propaganda and financial incentives. The medical industry, she suggests, profits both from vaccine sales and from treating the chronic diseases that vaccination itself causes.


9. Natural Immunity and the Path to Health

McBean advocates for a return to natural health principles. She teaches that true immunity arises from vitality, nutrition, rest, sunlight, and toxin-free living — not from artificial injections.

She encourages natural detoxification methods such as fasting, clean diets, and avoidance of chemical exposure. Disease, she writes, is not an external enemy but a healing and cleansing process within the body.


10. The Moral and Spiritual Dimension

In her conclusion, McBean views the vaccine system as a moral and spiritual corruption of natural law. She condemns forced vaccination as a violation of bodily autonomy and human conscience.

She urges readers to question authority, research independently, and reclaim responsibility for their own health. To her, resisting vaccination is both a personal and ethical act — one that defends life, freedom, and truth for future generations.


Key Takeaways

  • Written in 1957, this book challenges the entire foundation of vaccination science.
  • Vaccines were introduced without proof of safety or necessity.
  • Disease decline resulted from hygiene and nutrition, not vaccines.
  • Vaccines introduce poisons that damage health and lower resistance.
  • Many chronic and degenerative diseases trace back to vaccination.
  • Government and medical systems conceal evidence and protect profits.
  • Smallpox and polio are presented as prime examples of vaccine failure.
  • Health depends on natural living, not chemical or biological interference.
  • Fear and propaganda maintain public compliance.
  • Bodily sovereignty and informed choice are central moral rights.

If the content has concerned you in any way, feel free to download this accompanying worksheet to clarify any processes you have following reading this book review.

You can purchase the book here.

A Collation of Reports, Databases, and Warnings About C-19 Vaccines

Recorded After the Jab – Overview

The article states that no one knows how many people the experimental COVID-19 vaccines are killing now or will kill in future. It says many deaths and injuries have occurred after vaccination but are not being highlighted by mainstream media. It points readers to VAERS and OpenVAERS, noting OpenVAERS’ statement that fewer than 1% of adverse events are reported. It cites the UK Yellow Card data and notes a standard disclaimer now placed on UK Pfizer and AstraZeneca analysis prints that a reported adverse reaction does not necessarily mean causation.

The article contrasts this with how COVID-19 deaths were tallied after positive tests and suggests vaccine-proximate deaths should be treated analogously.

Reporting Systems and Disclaimers

Using UK data headings for Pfizer and AstraZeneca, the piece lists reported post-vaccination problems: strokes, heart attacks, miscarriages, Bell’s palsy, sepsis, paralysis, psychiatric disorders, blindness, deafness, shingles, menstrual problems, alopecia, and COVID-19 itself. It links to the European database of suspected adverse drug reactions. It highlights the recurring disclaimer that adverse reports do not prove causation and juxtaposes this with the method of attributing deaths to COVID-19 after positive tests.

Catalogue of Reported Events and Sources

A large portion is an itemised catalogue of links to articles, videos, and websites describing injuries and deaths following vaccination. These include case histories, whistleblower testimonies, compensation cases, regulatory notices, and numerical summaries by various outlets. Themes across the links include myocarditis, pericarditis, cardiac arrests, neurological disorders, autoimmune conditions, miscarriages, stillbirths, sudden deaths in athletes and young people, and alleged spikes in all-cause mortality and insurance claims.

“Important Note” on Clots, Deaths, and Efficacy

The article states that blood clots are not limited to AstraZeneca; it says all experimental vaccines have been associated with clots. It asserts there have been many deaths (stating over 1,000 in the UK) and a vast number of adverse events. It says these vaccines are experimental, given to healthy people, do not prevent COVID-19 or transmission, and that the risk of a young, healthy adult dying of COVID-19 is extremely small.

Examples and Compilations the Article Cites

The link list spans multiple countries and contexts: children and teenagers with myocarditis or death shortly after vaccination; adults with heart attacks, strokes, paralysis, amputations, or sudden collapse; athlete collapses; and whistleblower statements from nurses, doctors, and airline pilots. There are references to school districts training for “sudden cardiac arrest,” and to alleged increases in stillbirths and life-insurance claims. The article includes pointers to “confidential documents,” database tallies, and analyses claiming tens of thousands of deaths and millions of injuries.

FDA Draft Working List (Pre-Rollout)

The article reproduces (by reference) the U.S. FDA’s October 2020 “draft working list” of possible COVID-19 vaccine adverse event outcomes. It enumerates: Guillain-Barré syndrome; various encephalitis/encephalomyelitis/myelitis presentations; meningitis/meningoencephalitis; encephalopathy; seizures; stroke; narcolepsy/cataplexy; anaphylaxis; acute myocardial infarction; myocarditis/pericarditis; autoimmune disease; death; pregnancy and birth outcomes; demyelinating diseases; non-anaphylactic allergic reactions; thrombocytopenia; disseminated intravascular coagulation; venous thromboembolism; arthritis/arthralgia/joint pain; Kawasaki disease; multisystem inflammatory syndrome in children; and vaccine-enhanced disease. The article urges vigilance for these conditions after vaccination.

“Yet Another Coincidence” Section on Deaths

In a subsection titled “Deaths Shortly After Covid Jab – Yet Another Coincidence,” the article lists news items where people died shortly after vaccination alongside official remarks that a link had not been established or was unlikely. The juxtaposition emphasises temporal proximity while noting authorities’ statements of no proven connection.

Other Vaccine-Related Materials the Article Points To

The article links to materials about online censorship, regulatory pauses or age restrictions, mixing vaccine brands, anaphylaxis rates, and policy shifts in different countries. It includes items about spike protein concerns, calls to halt vaccination, contractual and legal matters, life-insurance positions, and characterisations of mRNA products. It also references world maps of side effects and alleged “pathogenic priming” in older adults.

Athletes and Sudden Health Events

A dedicated section lists named athletes, referees, and sports figures (teens to early 30s) who collapsed, developed heart conditions, suffered embolisms, or died, with ages and brief descriptors. The piece presents the list for readers to consider whether the jab may have been involved, highlighting the rarity of such issues in “superfit” individuals who typically undergo screenings.

Informed Consent, Recognition, and Under-Reporting

The article repeats the themes that adverse events are under-reported and that media and authorities downplay or deny links. It says governments do not practise fully informed consent and states many side effects will never be recognised. It contrasts perceived low COVID-19 mortality risk for young, healthy adults with the potential harms it associates with the vaccines, and it characterises the rollout as preceding the usual tests and observations.

Proposed Comparative Study

The piece concludes by proposing a “simple, cheap trial”: track health problems in 20,000 vaccinated people and compare them with 20,000 unvaccinated over 3, 6, and 12 months, overseen by “honest doctors.” It says such a study would yield “very interesting results” but expresses doubt that authorities will perform it.


Key takeaways (as stated in the article)

  • Many deaths and injuries are said to have occurred after COVID-19 vaccination and are not acknowledged by mainstream media; readers are directed to VAERS, Yellow Card, the European database, and numerous compilations.

  • Standard disclaimers about causation in adverse event reporting are presented as diverting attention; the article contrasts this with COVID-19 death counting after positive tests.

  • All experimental COVID-19 vaccines are described as associated with blood clots, with many deaths and a vast number of adverse events, including among young people.

  • Extensive case lists and testimonies describe myocarditis, pericarditis, strokes, neurological injuries, miscarriages, sudden deaths, and athlete collapses temporally following vaccination.

  • The FDA’s October 2020 draft working list of possible adverse events is reproduced and presented as a vigilance guide.

  • Vaccines are described as experimental, not preventing disease or transmission; the article states young, healthy adults face very small COVID-19 mortality risk relative to vaccine risks.

  • Claims of censorship, under-reporting, regulatory pauses, and legal/contractual issues are collated as context.

  • A vaccinated vs. unvaccinated cohort comparison is proposed as a straightforward safety assessment, with doubt expressed that it will be undertaken.

The Mask Debate Revisited: Health, Freedom, and the Cost of Compliance

Summary of Vernon Coleman’s “Proof That Face Masks Do More Harm Than Good” (Second Edition)

Overview

Vernon Coleman’s work compiles research studies, medical papers, and anecdotal evidence to argue that face masks, rather than protecting health, cause measurable physical and psychological harm. He challenges the scientific basis for mask mandates and explores broader ethical, medical, and social implications of enforced compliance.


1. Origins and Rationale

Coleman states that mask mandates were introduced without robust clinical proof of effectiveness. He notes that before 2020, public health guidance in several countries explicitly advised against general mask use for viral protection. He argues the shift in policy was political, not scientific, and contends that studies before and during the pandemic show no consistent benefit in reducing viral transmission in public settings.


2. Questioning Mask Effectiveness

The author references numerous trials and reviews which he claims demonstrate:

  • No statistically significant difference in infection rates between masked and unmasked groups.
  • Viral particles being too small to be filtered effectively by standard or cloth masks.
  • Mixed results even in healthcare settings, where mask fit and hygiene are more tightly controlled.
  • He concludes that mask policies were based on precautionary assumptions rather than proven outcomes.

3. Reported Physical Effects

Coleman lists a wide range of physical side effects he attributes to prolonged mask use:

  • Reduced oxygen levels (hypoxia) and raised carbon dioxide (hypercapnia) leading to fatigue, dizziness, headaches, and slower cognitive response.

  • Respiratory strain and potential exacerbation of existing lung or heart conditions.

  • Microbial growth in damp or reused masks, raising risks of bacterial and fungal infections.

  • Skin and dental issues, including rashes, acne, and gum inflammation.

  • Particle inhalation from mask fibres or synthetic materials.

He cites studies and case reports indicating that these effects can accumulate with extended wear, particularly in occupational or school environments.


4. Psychological and Social Impact

Coleman argues that masks alter communication, emotional connection, and self-perception.

  • Children, he says, may suffer developmental and social delays when facial expression is obscured.
  • Adults may experience anxiety, detachment, and loss of trust in social interactions.
  • Masking is a form of enforced conformity that encourages compliance rather than informed consent.
  • He views the psychological cost as an overlooked consequence of prolonged mask mandates.

5. Ethical and Legal Dimensions

Coleman emphasises personal autonomy and informed consent as central medical principles. He argues that no government or employer should compel mask use without conclusive evidence of benefit. The text references legal exemptions for those unable to tolerate masks for health reasons and encourages individuals to assert such rights. He also claims that dissenting scientific views have been censored or discredited to maintain policy unity.


6. Alternatives and Recommendations

While rejecting mask mandates, Coleman recognises that some may still be required to wear coverings. He considers face visors less restrictive and more breathable, though he views both masks and visors as offering minimal viral protection. His principal recommendation is individual choice guided by personal health, not government directive.


7. Conclusion

Coleman concludes that:

  • Mask mandates lack solid scientific support.
  • Masks pose multiple physical and psychological risks.
  • Policies enforcing them undermine medical freedom and human rights.
  • Future health measures should prioritise autonomy, transparency, and evidence over fear or conformity.

Key Takeaway Points

  • No proven community-level benefit of masks against viral spread.
  • Reported harms: reduced oxygen, increased CO₂, microbial growth, skin and dental issues.
  • Psychological effects: anxiety, impaired communication, developmental delay in children.
  • Ethical concern: violation of informed consent and personal freedom.
  • Coleman’s central assertion: face masks cause more harm than good and should remain a matter of personal choice.

Silenced Voices

Vernon Coleman’s Challenge to the Vaccine Narrative

In his September 2025 address, author and former GP Vernon Coleman outlines his concerns about vaccination policy, media control, and what he regards as the pharmaceutical industry’s dominance of modern medicine. He introduces the talk by noting that many of his earlier videos have been removed from major online platforms, which he interprets as suppression of dissenting medical opinion.

Government statements and loss of debate

Coleman refers to remarks attributed to Stephen Kinnock MP, Minister of State for Care, who allegedly told the BBC that vaccines are “100 percent safe” and that the Government intends to silence conspiracy theorists and misinformers on social media.

Coleman argues that no medical intervention can ever be “entirely without risk” and that the credibility of public health policy depends on open discussion, not the silencing of critics. He says that when officials exaggerate safety claims, they risk alienating informed members of the public.

Historical background and risk examples

To support his view, Coleman revisits a series of historical vaccine incidents described in his earlier works.

These include the 1930 BCG contamination in Germany, in which 72 children reportedly died; the 1955 Cutter polio vaccine incident in the US; and surveys from the 1960s and 1970s linking the whooping-cough vaccine with neurological reactions.

He notes that governments in several countries have compensation schemes for vaccine injury, which he interprets as official acknowledgement that adverse reactions can occur.

From this, Coleman concludes that vaccines are not entirely without risk, and that historical data demonstrate a need for transparency.

Pharmaceutical funding and professional incentives

Coleman asserts that pharmaceutical companies exert significant influence over modern medicine.
He describes how industry sponsorship extends from research and medical education to public-health messaging, creating an information environment shaped by commercial priorities.

He adds that general practitioners receive payments or bonuses for administering vaccines, which, in his view, introduces a conflict of interest by rewarding compliance with vaccination targets rather than independent judgment.

Several doctors who have written to him reportedly share this concern, stating that professional advancement and income depend on adherence to official vaccination policy.

Media control and omission of history

Coleman contends that mainstream media and official channels restrict dissenting discussion about vaccine safety.

He recounts being invited, then removed, from a PasTest medical conference on adverse-drug reactions, where he was told that certain parties considered him “too controversial.”

He argues that this pattern extends across broadcasting and print outlets such as the BBC, which he says operate under editorial rules that prevent critical perspectives on vaccination.

In his view, this selective presentation of information contributes to what he calls public “amnesia” about medical history.

He “reminds” audiences that Edward Jenner’s first son, who received an early smallpox vaccination, allegedly developed brain damage and died young, while Jenner did not vaccinate his second son.

Coleman presents this as an example of how historical complexities are omitted or simplified in favour of a single, unquestioned narrative.

The COVID-19 vaccine discussion

Addressing the pandemic period, Coleman describes the COVID-19 vaccine as ineffective and risky, particularly for children and pregnant women.

He refers to early reports from the US CDC that he interprets as showing notable rates of severe adverse reactions and cites the WHO’s acknowledgement that the vaccine does not fully prevent infection or transmission.

He lists possible effects reported by some clinicians—neurological and cardiac events, fertility concerns, and inflammatory responses—and argues that further independent investigation is required.

Coleman and several doctors he references question why debate on these issues has been discouraged, suggesting that financial and political pressures have replaced scientific evaluation.

Broader conclusions

Coleman concludes that medicine has become increasingly funded and directed by Big Pharma, with public agencies and mainstream media aligned to reinforce official positions.

He argues that, as a result, dissenting doctors and researchers face reputational risk if they question prevailing assumptions.

He maintains that the principle of scientific integrity demands unrestricted discussion and peer review of medical evidence, including data that challenge current policy.

For Coleman and those who share his outlook, restoring open debate is essential to rebuilding trust between the public, clinicians, and health authorities.


Summary of Core Assertions Presented in the Address

  • Vaccines are not entirely without risk: historical examples illustrate adverse outcomes.

  • Pharmaceutical companies have extensive influence over research, education, and public messaging.

  • Doctors’ incentives: GPs receive bonuses or payments for vaccinations, shaping professional behaviour.

  • Historical omission: mainstream narratives simplify vaccine history, producing public “amnesia.”

  • Media restriction: outlets such as the BBC deliberately exclude dissenting or critical discussion.

  • COVID-19 vaccine: insufficiently tested and potentially risky, especially for vulnerable groups.

  • Open debate: Many doctors call for unrestricted examination of medical evidence to safeguard scientific transparency.

The C-19 vaccine, risk, limitations, benefits

COVID-19 Vaccination: Current Evidence, Documented Effects, and Ongoing Areas of Research

Context

COVID-19 vaccines were developed to reduce infection, severe disease, and death associated with SARS-CoV-2. mRNA, protein-based, and adenoviral-vector platforms have been deployed internationally since late 2020. Surveillance systems such as the MHRA Yellow Card scheme, the US VAERS database, and European EudraVigilance record post-marketing safety data and are continuously updated.


Effectiveness

  • Relative risk reduction (RRR): analyses for 2024–25 show reductions of approximately 30–45 % in hospitalisation compared with unvaccinated populations during high-transmission periods.

  • Absolute risk reduction (ARR): varies with baseline risk. In adults aged 65 years and above with a hospitalisation risk of about 1 %, vaccination reduced that risk by 0.4–0.5 percentage points. In healthy adults under 40 years with a risk near 0.05 %, the reduction was approximately 0.02 percentage points.

  • Protection against infection declines over several months; protection against severe outcomes remains longer but also wanes with time.


Reported or Studied Safety Issues

Myocarditis and Pericarditis

Identified after mRNA vaccination, occurring more in males under 30 and after second doses. Surveillance data record several tens of reports per million doses (it’s estimated that 10% of adverse reactions are recorded so these figures may be demonstrably higher). Research is ongoing into mechanisms and long-term cardiac outcomes.

Thrombosis with Thrombocytopenia (VITT or TTS)

Recorded after adenoviral-vector vaccines. Incidence in monitoring systems is about two to three cases per million doses. Studies continue on immune triggers and susceptibility factors.

Neurological Events

Guillain-Barré syndrome and Bell’s palsy have been reported following vaccination. Incidence data are comparable with pre-pandemic background levels. Temporal and mechanistic relationships remain under investigation.

Autoimmune or Inflammatory Syndromes

Autoimmune-type and inflammatory conditions have been described. Work continues to identify possible risk modifiers and biological pathways.

Rapid-Onset or “Turbo” Cancers

Reports exist of aggressive or rapidly developing cancers detected after vaccination. Cancer registries suggest that increases are due to screening backlogs and delayed treatment during the pandemic, but this is disputed. The relationship between vaccination and tumour progression is under research (Angus Dalgliesh).

Cognitive Decline and Dementia

A 2024 South-Korean cohort study (QJM) reported an association between vaccination and subsequent diagnoses of mild cognitive impairment and Alzheimer’s disease in individuals aged ≥ 65. Replication and extended follow-up are in progress. This association is being researched (https://pubmed.ncbi.nlm.nih.gov/38806183/).

Fertility and Miscarriage and Reproductive Outcomes

Thorp et al. analysed data from vaccine adverse-event reports to compare outcomes following COVID-19 vaccination with those following influenza vaccination. Their report identified higher proportional reporting ratios for miscarriage, foetal malformations, foetal cardiac disorders, foetal growth anomalies, stillbirth, preterm delivery, placental anomalies, and menstrual abnormalities in the COVID-19-vaccinated group. They concluded the findings warranted further research into placental pathology, spike-protein biodistribution, and inflammatory mechanisms during pregnancy.

Using three normalization methods (by time, by doses, and by persons vaccinated), the study finds consistent and strong “safety signals.”

Based on these findings, the authors argue for an immediate worldwide moratorium on COVID-19 vaccination in pregnant women and caution in women of reproductive age, until long-term safety data are available. They  contend the observed signals are strong enough to merit policy change.

Full text (clickable link)

Sudden or Unexplained Death in Adults

Health authorities in several countries review mortality data to assess reports of unexpected or unexplained deaths following COVID-19 vaccination. Post-marketing surveillance systems such as the UK MHRA Yellow Card programme, the US Vaccine Safety Datalink and other registries track deaths reported in proximity to vaccination and consequently it is deemed there is limited verifiable data available save anecdotal from those who have lost loved ones suddenly following the roll out. Sudden-death cases have usually been linked to cardiovascular or other conditions rather than vaccination because that would be deemed “misinformation” so readers are advised to research for themselves. Research continues into rare cardiac or arrhythmic events, including myocarditis.


Data Limitations

  • Observational studies do not establish causation; confounding and reporting biases can influence results.
  • Passive-reporting databases capture all events after vaccination, regardless of proven linkage.
  • Population risks vary with age, health status, variant circulation, and time since previous infection or dose.

Ongoing Research Topics

  • Duration of spike-protein expression and immune activation (click the link for a spike protein detox or see here:  for information (please be aware that mainstream deems this as “baseless” so keep an open mind and research for yourself)
  • Chronic-inflammation and autoimmune mechanisms.
  • Long-term neurological, oncological, and reproductive health outcomes.

Summary

Evidence to date indicates limited (arguably measurable) protection against severe COVID-19, but arguably in older or medically vulnerable adults.  Adverse events have been identified and quantified through surveillance. Several associations—cardiac, neurological, oncological, and cognitive—are the subject of continuing research to determine frequency, mechanism, and potential causality. Readers can verify data directly from public databases and peer-reviewed studies to inform personal and clinical decision-making.


Further reading – here are two books which the “mainstream” claim as mis/disinformation and contrary to publicly available guidance – you can make your own minds up regarding these but bear in mind that minds have been closed due to repetitive guidance and big pharma funding; the author is not claiming anything by citing them, simply considering an alternative viewpoint; both authors have studied scientific, medical and professional literature to start asking the questions – then consider is this considering terrain theory more extensively – i.e. hygiene,  nutrition, sanitation and toxins in the environment that play a greater part in overall human health?  I leave that question open:

Can You Catch a Cold? by Daniel Roytas

Subtitle: Untold History & Human Experiments

Here are six key themes or findings from that book:

  1. Challenge to contagion theory
    Roytas reviews over 200 human “contagion experiments” and claims that many fail to show consistent transmission of cold or flu from sick to healthy volunteers. He argues this suggests the standard notion of catching a cold via droplets or contact is not fully validated.

  2. Historical record & lost data
    The author examines old medical literature and records, arguing that much early work that questioned germ theory was suppressed or forgotten. He suggests that alternative models of disease were side-lined as germ theory became dominant.

  3. Environmental, metabolic, and stress factors
    Roytas proposes that many “cold and flu” symptoms may arise from environmental exposures (temperature shifts, pollutants), nutritional or metabolic imbalances, and stress rather than a transmissible virus.

  4. Psychological / nocebo influence
    The book discusses how expectation, belief, or fear (nocebo effect) may influence symptom development or perceived illness, particularly in group settings.

  5. Questioning viral isolation and proof methods
    Roytas scrutinises virology methods, especially claims of isolation, purification, and re-infection tests. He contends those methods have methodological gaps or rely on inference rather than direct proof.

  6. Alternative disease framework
    The book advocates a return to older frameworks (terrain theory, detoxification, innate resilience) as potentially more valid than germ-driven models, especially when viral causation is uncertain.


Virus Mania by Torsten Engelbrecht, Claus Köhnlein, Samantha Bailey, et al.

Here are six prominent themes from Virus Mania:

Viruses as unproven hypotheses
The authors argue that the existence, pathogenicity, and disease-causing role of many viruses (including SARS-CoV-2, measles, influenza) lack proof according to their standards. They contend that protocols claiming isolation rely on indirect methods (PCR, antibody inference, culture with host cells) rather than pure virus particles.

Critique of laboratory methods (PCR, antibodies, culture)
Virus Mania claims that molecular tools (PCR amplification, antibody binding assays) and cell culture are used to re-assemble viral genomes without having truly isolated intact virions, thus introducing circular logic in virus detection.

Diseases as cellular stress / metabolic response
The book proposes that symptoms attributed to viruses are better explained as responses to cell stress, toxicity (pollutants, chemicals, vaccines), metabolic disruption, or other environmental insults—not invasion by an external pathogen.

Disease “epidemics” as social narrative & medical industry factor
The authors assert the medical and pharmaceutical industries promote fear of viruses to justify vaccines, diagnostics, and profits. They discuss how media amplification, testing campaigns, and redefining normal thresholds contribute to perceived epidemics.

Historical reinterpretation
The text revisits past epidemics (Spanish flu, polio, smallpox) and argues that poor sanitation, malnutrition, and chemical exposures may have been more contributory than viral spread. It questions mainstream historical narratives about vaccine successes.

Call for virus redefinition & paradigm shift
The authors call for a reassessment of virology fundamentals, proposing that one should redefine “virus,” revisit Koch’s postulates, and adopt broader models of disease causation that prioritize cellular health rather than pathogen-focused models.


Please bear in mind “Vaccine Amnesia: How the Media Used to Report Vaccine Injuries” by A Midwestern Doctor from the USA

The article outlines how vaccine-related injuries and safety controversies were once covered in mainstream media but are no longer widely discussed. It presents a timeline of historical examples illustrating shifts in media reporting and public awareness.

Early Vaccine Incidents

Polio Vaccine (1950s–60s): Describes the Cutter incident, where some batches of the Salk polio vaccine caused paralysis. Mentions later discoveries of SV40 contamination and subsequent regulatory reforms.
Swine Flu Vaccine (1976): Notes the suspension of the U.S. programme following reports of Guillain–Barré syndrome, and highlights how coverage of vaccine side effects was widespread at the time.

Later Vaccine Controversies
DTP (Pertussis) Vaccine: Discusses reported cases of neurological injury and the formation of advocacy groups calling for reform. Mentions early television and newspaper investigations into these reports.
Hepatitis B Vaccine: Describes expansion of vaccination to newborns and low-risk groups, with media attention on cases alleging injury.
Anthrax Vaccine: Outlines complaints by military personnel and investigations into manufacturing and testing issues.
HPV (Gardasil): Lists reports of autoimmune and neurological issues after vaccination, and notes the presence of earlier critical news segments on the topic.
Influenza Vaccine: Summarises periodic public debates over effectiveness and risk.
Autism and Vaccines: References coverage in early 2000s television segments that discussed possible associations and government conflict-of-interest concerns.

Media Changes

The article states that, in the past, newspapers and television networks investigated vaccine safety concerns, whereas today similar stories are largely absent. It attributes this change to:

  • Financial dependence on pharmaceutical advertising.
  • Government partnerships with media outlets to promote vaccination.
  • Professional pressure on journalists and editors not to publish critical vaccine stories.
  • Decline of investigative journalism and rise of centralised media ownership.

Examples of Journalists and Media Figures

The article lists reporters who previously covered vaccine injury topics but later left mainstream outlets, including Sharyl Attkisson, Tucker Carlson, and Megyn Kelly.

Recent Context

The article compares historical vaccine controversies to the COVID-19 vaccine rollout, suggesting recurring patterns in how adverse events are discussed and reported.

Conclusion

The author introduces the concept of “vaccine amnesia,” describing a societal pattern of forgetting previous vaccine controversies once new programmes are introduced. The article concludes that this forgetting enables the repetition of past mistakes and limits open public discussion about vaccine safety.

Page 1 of 2

Powered by WordPress & Theme by Anders Norén